Table 7.

Elastic Net multivariable analysis for A2 or A3 versus A1 proteinuria

Variable	Category	V5 Model			V10 Model			V15 Model			V20 Model
		OR	95% CI	P Value	OR	95% CI	P Value	OR	95% CI	P Value	OR	95% CI	P Value
Sex	Men versus women	1.43	1.00 to 2.04	0.05	1.43	1.00 to 2.04	0.05	1.42	1.00 to 2.03	0.05	1.41	0.99 to 2.01	0.06
Race/ethnicity	Other versus non-Hispanic White	2.34	1.59 to 3.44	<0.001	2.34	1.59 to 3.44	<0.001	2.32	1.58 to 3.41	<0.001	2.31	1.57 to 3.39	<0.001
Body mass index, kg/m2	≥25 to <30 versus >13 to <25	0.65	0.39 to 1.09	0.10	0.65	0.39 to 1.09	0.10	0.65	0.39 to 1.08	0.10	0.65	0.39 to 1.09	0.10
Body mass index, kg/m2	≥30 versus >13 to <25	1.51	0.98 to 2.31	0.06	1.50	0.98 to 2.31	0.06	1.50	0.98 to 2.30	0.06	1.51	0.99 to 2.32	0.06
Hypertension (CTCAE)	Grade ≥2 versus <2	2.62	1.81 to 3.79	<0.001	2.62	1.81 to 3.79	<0.001	2.63	1.82 to 3.81	<0.001	2.61	1.80 to 3.77	<0.001
Diabetes mellitus (CTCAE)	Grade ≥2 versus <2	1.19	0.70 to 2.02	0.51	1.19	0.70 to 2.02	0.51	1.19	0.70 to 2.01	0.53	1.19	0.70 to 2.01	0.53
Nephrectomy	Yes versus no	2.21	1.25 to 3.90	0.006	2.21	1.25 to 3.89	0.006	2.37	1.38 to 4.07	0.002	2.36	1.37 to 4.05	0.002
Doses of Abelcet/AmBisome	Per dose	1.03	0.99 to 1.06	0.11	1.03	0.99 to 1.06	0.11	1.03	1.00 to 1.06	0.09	1.03	1.00 to 1.06	0.08
Doses of amphotericin B	Per dose	1.02	1.00 to 1.04	0.02	1.02	1.00 to 1.04	0.02	1.02	1.01 to 1.04	0.006	1.02	1.01 to 1.04	0.006
V5	Per 1%	1.00	1.00 to 1.01	0.26
V10	Per 1%				1.00	1.00 to 1.01	0.24
V15	Per 1%							1.01	1.00 to 1.02	0.17
V20	Per 1%										1.01	1.00 to 1.03	0.07

95% CI, 95% confidence interval; CTCAE, Common Terminology Criteria for Adverse Events.